Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Clinical oncology and error reduction. / / Antonella Surbone, Michael Rowe
| Clinical oncology and error reduction. / / Antonella Surbone, Michael Rowe |
| Autore | Surbone Antonella |
| Pubbl/distr/stampa | West Sussex, England : , : John Wiley & Sons, Inc., , 2015 |
| Descrizione fisica | 1 online resource (207 p.) |
| Disciplina | 616.99/4 |
| Soggetto topico |
Cancer - Patients
Medical errors - Prevention |
| ISBN |
1-118-74927-8
1-118-74905-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; List of contributors; Foreword; Preface; Acknowledgment; Chapter 1 Introduction to oncology and medical errors; Part I Medical errors and oncology: background and context; Chapter 2 Recognizing and facing medical errors: the perspective of a physician who is also the patient; Chapter 3 Psychological and existential consequences of medical error for oncology professionals; Chapter 4 To sue or not to sue: restoring trust in patient-doctor-family relationships; Part II Improving patient safety in clinical oncology practice
Chapter 5 Prevention of errors and patient safety: oncology nurses' perspectivesChapter 6 Prevention of errors and patient safety from the oncologist's perspective; Chapter 7 Disclosing harmful medical errors; Chapter 8 Do cross-cultural differences influence the occurrence and disclosure of medical errors in oncology?; Part III Cancer patients, oncology professionals, and institutions against medical errors; Chapter 9 Prevention of errors and patient safety: institutional perspectives Chapter 10 Professional and ethical responsibilities in adverse events and medical errors: discussions when things go wrongChapter 11 Medical error and patient advocacy; Chapter 12 Conclusion: the ""given"" and ""therefores"" of clinical oncology and medical errors; Index; EULA |
| Record Nr. | UNINA-9910818949803321 |
Surbone Antonella
|
||
| West Sussex, England : , : John Wiley & Sons, Inc., , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical problems in oncology : a practical guide to management / / edited by Sing Yu Moorcraft, Daniel L. Y. Lee, David Cunningham ; Emma Dugdale [and eight others], contributors
| Clinical problems in oncology : a practical guide to management / / edited by Sing Yu Moorcraft, Daniel L. Y. Lee, David Cunningham ; Emma Dugdale [and eight others], contributors |
| Pubbl/distr/stampa | Chichester, England : , : Wiley-Blackwell, , 2014 |
| Descrizione fisica | 1 online resource (340 p.) |
| Disciplina | 616.99/4 |
| Soggetto topico | Tumors |
| ISBN |
1-118-67381-6
1-118-67376-X 1-118-67386-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Problems in Oncology; Copyright; Contents ; List of contributors ; Preface ; Acknowledgements; List of abbreviations; Chapter 1 Introduction to clinical problems in oncology ; General approach to the management of oncology patients; Types of treatment; Tumour types and extent of disease; Other important tumour characteristics; Decision making in cancer patients; Assessing response to treatment; References; Performance status; Tumour markers; Overview; Current uses of tumour markers; Common tumour markers; Other relevant sections of this book; References
Chapter 2 Oncological emergencies Anaphylaxis and hypersensitivity reactions; Definition; Causes; Symptoms and signs; Management; Localised hypersensitivity reaction; Anaphylaxis; Observation a nd biphasic reactions; Ongoing management and retreatment; References; Bleeding; Overview; Clinical presentation; Clinical assessment; Management; Disseminated intravascular coagulopathy (DIC); End of life considerations/catastrophic bleed; Other relevant sections of this book; References; Central airway obstruction and stridor; Definition; Causes; Symptoms; Investigation; Management; References ExtravasationDefinition; Risk factors and prevention of extravasation; Diagnosis; Differential diagnoses; Management; Central venous device extravasation; Recall injury; Surgical referral; References; Febrile neutropenia; Definition; Background; Assessment; Management; Future cancer management; References; Hypercalcaemia; Symptoms/signs; Causes; Management; References; Non-neutropenic sepsis; Definitions; Presentation and management; Other relevant sections of this book; References; Raised intracranial pressure and seizures; Raised intracranial pressure (ICP); Seizures; References Spinal cord compressionDefinition; Presentation; Risk factors; Early detection of spinal metastases; MSCC as an oncological emergency; Treatment; Management after definitive treatment; References; Superior vena cava obstruction; Causes; Presentation; Investigations; Treatment; References; Transfusion reactions; Mild fever only; Urticaria/mild allergic reaction only; ABO incompatibility; Severe allergic reaction; Haemolytic reaction or bacterial infection of unit of transfusion; Acute dyspnoea/hypotension; Other relevant sections of this book; References; Tumour lysis syndrome; Definition ClassificationCauses; Risk assessment; Management; Other relevant sections of this book; References; Chapter 3 Side effects and complications of cancer and its treatment ; Overview of toxicity management; Assessment and documentation of toxicities; Advice to patients; Principles of toxicity management; Effects of dose reductions and/or delays on treatment efficacy; References; Abnormal liver function tests; Abnormal liver function; Assessment; Causes of hepatitic liver dysfunction; Causes of obstructive liver dysfunction; Investigations; Management; Prescribing and liver function Other relevant sections of this book |
| Record Nr. | UNINA-9910139123003321 |
| Chichester, England : , : Wiley-Blackwell, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical problems in oncology : a practical guide to management / / edited by Sing Yu Moorcraft, Daniel L. Y. Lee, David Cunningham ; Emma Dugdale [and eight others], contributors
| Clinical problems in oncology : a practical guide to management / / edited by Sing Yu Moorcraft, Daniel L. Y. Lee, David Cunningham ; Emma Dugdale [and eight others], contributors |
| Pubbl/distr/stampa | Chichester, England : , : Wiley-Blackwell, , 2014 |
| Descrizione fisica | 1 online resource (340 p.) |
| Disciplina | 616.99/4 |
| Soggetto topico | Tumors |
| ISBN |
1-118-67381-6
1-118-67376-X 1-118-67386-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Problems in Oncology; Copyright; Contents ; List of contributors ; Preface ; Acknowledgements; List of abbreviations; Chapter 1 Introduction to clinical problems in oncology ; General approach to the management of oncology patients; Types of treatment; Tumour types and extent of disease; Other important tumour characteristics; Decision making in cancer patients; Assessing response to treatment; References; Performance status; Tumour markers; Overview; Current uses of tumour markers; Common tumour markers; Other relevant sections of this book; References
Chapter 2 Oncological emergencies Anaphylaxis and hypersensitivity reactions; Definition; Causes; Symptoms and signs; Management; Localised hypersensitivity reaction; Anaphylaxis; Observation a nd biphasic reactions; Ongoing management and retreatment; References; Bleeding; Overview; Clinical presentation; Clinical assessment; Management; Disseminated intravascular coagulopathy (DIC); End of life considerations/catastrophic bleed; Other relevant sections of this book; References; Central airway obstruction and stridor; Definition; Causes; Symptoms; Investigation; Management; References ExtravasationDefinition; Risk factors and prevention of extravasation; Diagnosis; Differential diagnoses; Management; Central venous device extravasation; Recall injury; Surgical referral; References; Febrile neutropenia; Definition; Background; Assessment; Management; Future cancer management; References; Hypercalcaemia; Symptoms/signs; Causes; Management; References; Non-neutropenic sepsis; Definitions; Presentation and management; Other relevant sections of this book; References; Raised intracranial pressure and seizures; Raised intracranial pressure (ICP); Seizures; References Spinal cord compressionDefinition; Presentation; Risk factors; Early detection of spinal metastases; MSCC as an oncological emergency; Treatment; Management after definitive treatment; References; Superior vena cava obstruction; Causes; Presentation; Investigations; Treatment; References; Transfusion reactions; Mild fever only; Urticaria/mild allergic reaction only; ABO incompatibility; Severe allergic reaction; Haemolytic reaction or bacterial infection of unit of transfusion; Acute dyspnoea/hypotension; Other relevant sections of this book; References; Tumour lysis syndrome; Definition ClassificationCauses; Risk assessment; Management; Other relevant sections of this book; References; Chapter 3 Side effects and complications of cancer and its treatment ; Overview of toxicity management; Assessment and documentation of toxicities; Advice to patients; Principles of toxicity management; Effects of dose reductions and/or delays on treatment efficacy; References; Abnormal liver function tests; Abnormal liver function; Assessment; Causes of hepatitic liver dysfunction; Causes of obstructive liver dysfunction; Investigations; Management; Prescribing and liver function Other relevant sections of this book |
| Record Nr. | UNINA-9910806867203321 |
| Chichester, England : , : Wiley-Blackwell, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / [edited by] Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg
| DeVita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / [edited by] Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg |
| Edizione | [10th ed.] |
| Pubbl/distr/stampa | Philadelphia, : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2015 |
| Descrizione fisica | 1 online resource (2280 pages) |
| Disciplina | 616.99/4 |
| Altri autori (Persone) |
DeVitaVincent T., Jr., <1935->
LawrenceTheodore S RosenbergSteven A |
| Soggetto topico |
Cancer
Oncology Neoplasms |
| ISBN |
1-4698-9455-6
1-4963-2467-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cancer Principles & -- Practice of Oncology -- CONTRIBUTORS -- PREFACE -- Acknowledgments -- CONTENTS -- PART I Principles of Oncology -- 1 Cancer Genome -- introduction -- CANCER GENES AND THEIR MUTATIONS -- IDENTIFICATION OF CANCER GENES -- SOMATIC ALTERATION CLASSES DETECTED BY CANCER GENOME ANALY SIS -- PATHWAY-ORIENTED MODELS OF CANCER GENOME ANALY SIS -- NETWORKS OF CANCER GENOME PROJECTS -- THE GENOMIC LANDSCAPE OF CANCERS -- INTEGRATIVE ANALY SIS OF CANCER GENOMICS -- THE CANCER GENOME AND THE NEW TAXONOMY OF TUMORS -- CANCER GENOMICS AND DRUG RESISTANCE -- PERSPECTIVES OF CANCER GENOME ANALY SIS -- Acknowledgments -- 2 Hallmarks of Cancer: An Organizing Principle for Cancer Medicine -- Introduction -- HALLMARK CAPABILITIES, IN ESSENCE -- TWO UBIQUITOUS CHARACTERISTICS FACILITATE THE ACQUISITION OF HALLMARK CAPABILITIES -- THE CONSTITUENT CELL TYPES OF THE TUMOR MICROENVIRONMENT -- THERAPEUTIC TARGETING OF THE HALLMARKS OF CANCER -- CONCLUSION AND A VISION FOR THE FUTURE -- Acknowledgment -- 3 Molecular Methods in Cancer -- Applications of Molecular Diagnostics in Oncology -- The Clinical Molecular Diagnostics Laboratory: Rules and Regulations -- Specimen Requirements for Molecular Diagnostics -- Molecular Diagnostics Testing Process -- Technologies -- PART II Etiology and Epidemiology of Cancer -- Section 1 Etiology of Cancer -- 4 Tobacco -- introduction -- EPIDEMIOLOGY OF TOBACCO AND CANCER -- CARCINOGENS IN TOBACCO PRODUCTS AND PROCESSES OF CANCER DEVELOPMENT -- 5 Oncogenic Viruses -- PRINCIPLES OF TUMOR VIROLOGY -- PAPILLOMAVIRUSES -- POLYOMAVIRUSES -- EPSTEIN-BARR VIRUS -- KAPOSI's SARCOMA HERPESVIRUS -- ANIMAL AND HUMAN RETRO VIRUSES -- HEPATITIS VIRUSES -- CONCLUSION -- 6 Inflammation -- Introduction -- MOLECULAR BASIS OF INFLAMMATION -- ROLE OF INFLAMMATION IN TRANSFORMATION -- ROLE OF INFLAMMATION IN SURVIVAL.
ROLE OF INFLAMMATION IN PROLIF ERATION -- ROLE OF INFLAMMATION IN INVASION -- ROLE OF INFLAMMATION IN ANGIOGENESIS -- ROLE OF INFLAMMATION IN META STASIS -- EPIGENETIC CHANGES AND INFLAMMATION -- ROLE OF INFLAMMATION IN CANCER DIAGNOSIS -- INFLAMMATION AND GENOMICS -- INFLAMMATION AND TARGETED THERAPIES -- CONCLUSIONS -- 7 Chemical Factors -- Introduction -- THE NAT URE OF CHEMICAL CARCINOGENS: CHEMISTRY AND META BOLISM -- ANIMAL MODEL SYSTEMS AND CHEMICAL CARCINOGENESIS -- MOLECULAR EPIDEMIOLOGY, CHEMICAL CARCINOGENESIS, AND CANCER RISK IN HUMAN POPULATION S -- ARISTOLO CHIC ACID AND UROT HELIAL CANCERS AS A MODEL FOR IDENTIFYING HUMAN CARCINOGENS -- 8 Physical Factors -- INTRODUCTION -- IONIZING RADIATION -- ULTRAVIOLET LIGHT -- RADIOFREQUENCY AND MICROWAVE RADIATION -- ELECTROMAGNETIC FIELDS -- ASBESTOS -- NANOPARTICLES -- 9 Dietary Factors -- Introduction -- METHODOLOGIC CHALLENGES -- THE ROLE OF INDIVIDUAL FOOD AND NUTRIENTS IN CANCER ETIOLOGY -- OTHER FOODS AND NUTRIENTS -- DIETARY PATTERNS -- DIET DURING THE EARLY PHASES OF LIFE -- DIET AFTER A DIAGNOSIS OF CANCER -- SUMMARY -- LIMITATIONS -- FUTURE DIRECTIONS -- RECOMMENDATIONS -- 10 Obesity and Physical Activity -- INTRODUCTION -- BREAST CANCER -- COLON AND RECTAL CANCER -- ENDOMETRIAL CANCER -- ADENOCARCINOMA OF THE ESOPHAGUS -- KIDNEY/RENAL CELL CANCER -- PANCREATIC CANCER -- GALLBLADDER CANCER -- NON-HODGKIN LYMPHOMA -- PROSTATE CANCER -- LUNG CANCER -- OVARIAN CANCER -- CONCLUSIONS -- Section 2 Epidemiology of Cancer -- 11 Epidemiologic Methods -- Introduction -- ANALYTICAL STUDIES -- INTERPRETATION OF EPIDEMIOLOGIC FINDINGS -- CANCER OUTCOMES RESEARCH -- MOLECULAR EPIDEMIOLOGY -- 12 Trends in United States Cancer Mortality -- INTRODUCTION -- CANCER SURVEILLANCE SYSTEMS -- MAKING SENSE OF CANCER TRENDS -- TRENDS IN CANCER RISK FACTORS AND SCREENING -- CANCER INCIDENCE AND MORTALITY. PREDICTING FUTURE CANCER TRENDS -- PART III Cancer Therapeutics -- 13 Essentials of Radiation Therapy -- INTRODUCTION -- BIOLOGIC ASPECTS OF RADIATION ONCOLOGY -- FACTORS THAT AFFECT RADIATION RESPONSE -- DRUGS THAT AFFECT RADIATION SENSITIVITY -- RADIATION PHYSICS -- TREATMENT PLANNING -- OTHER TREATMENT MODALITIES -- CLINICAL APPLICATIONS OF RADIATION THERAPY -- TREATMENT INTENT -- FRACTIONATION -- ADVERSE EFFECTS -- PRINCIPLES OF COMBINING ANTICANCER AGENTS WITH RADIATION THERAPY -- 14 Cancer Immunotherapy -- Introduction -- HUMAN TUMOR ANTIGENS -- HUMAN CANCER IMMUNOTHERAPIES -- 15 Pharmacokinetics and Pharmacodynamics of Anticancer Drugs -- INTRODUCTION -- PHARMACOKINETIC CONCEPTS -- PHARMACODYNAMIC CONCEPTS -- VARIABILITY IN PHARMACOKINETICS/ PHARMACODYNAMICS -- DOSE-ADAPTATION USING PHARMACOKINETIC/PHARMACODYNAMIC PRINCIPLES -- 16 Pharmacogenomics -- Introduction -- PHARMACOGENOMICS OF TUMOR RESPONSE -- PHARMACOGENOMICS OF CHEMOTHERAPY DRUG TOXICITY -- CONCLUSIONS AND FUTURE DIRECTIONS -- 17 Alkylating Agents -- PERSPECTIVES -- CHEMISTRY -- CLASSIFICATION -- CLINICAL PHARMACOKINETICS/ PHARMACODYNAMICS -- THERAPEUTIC USES -- TOXICITIES -- COMPLICATIONS WITH HIGH-DOSE ALKYLATING AGENT THERAPY -- ALKYLATING AGENT-STEROID CONJUGATES -- DRUG RESISTANCE AND MODULATION -- RECENT DEVELOPMENTS -- 18 Platinum Analogs -- Introduction -- HISTORY -- PLATINUM CHEMISTRY -- PLATINUM COMPLEXES AFTER CISPLATIN -- MECHANISM OF ACTION -- CELLULAR RESPONSES TO PLATINUM-INDUCED DNA DAMAGE -- IS DNA THE ONLY TARGET? -- MECHANISMS OF RESISTANCE -- CLINICAL PHARMACO LOGY -- FORMULATION AND ADMINISTRATION -- TOXICITY -- 19 Antimetabolites -- ANTIFOLATES -- 5-FLUOROPYRIMIDINES -- CAPECITABINE -- CYTARABINE -- GEMCITABINE -- 6-THIOPURINES -- FLUDARABINE -- CLADRIBINE -- CLOFARABINE -- 20 Topoisomerase Interactive Agents. CLASSIFICATION, BIOCHEMICAL, AND BIOLOGIC FUNCTIONS OF TOPOISOMERASES -- TOPOISOMERASE INHIBITORS AS INTERFACIAL POISONS -- Topoisomerase I Inhibitors : Camptothecins and Beyond -- TOPOISOMERASE II INHIBITORS: INTERCALATORS AND NONINTERCALATORS -- THERAPY-RELATED SECONDARY ACUTE LEUKEMIA -- FUTURE DIRECTIONS -- 21 Agents -- MICROTUBULES -- TAXANES -- VINCA ALKALOIDS -- MICROTUBULE ANTAGONISTS -- MITOTIC MOTOR PROTEIN INHIBITORS -- MECHANISMS OF RESISTANCE TO MICROTUBULE INHIBITORS -- 22 Kinase Inhibitors as Anticancer Drugs -- INTRODUCTION -- EARLY SUCCESSES: TAR GETING CANCERS WITH WELL-KNOWN KINASE MUTATI ONS (BCR-ABL, KIT, HER2) -- DIRECTLY TARGETING THE PI3K PATH WAY -- COMBINATIONS OF KINASE INHIBITORS TO INDUCT RESPONSE AND PREVENT RESISTANCE -- SPECULATI ONS ON THE FUTURE ROLE OF KINASE INHIBITORS IN CANCER MEDICINE -- 23 Histone Deacetylase Inhibitors and Demethylating Agents -- INTRODUCTION -- EPIGENETIC ABNORMALITIES AND GENE EXPRESSION CHANGES IN CANCER -- HISTONE DEACETYLASE INHIBITORS -- EPIGENETIC THERAPY FOR HEMATOLOGIC MALIGNANCIES -- NEW APROACHES TO EPIGENETIC THERAPY -- 24 Proteasome Inhibitors -- BIOCHEMISTRY OF THE UBIQUITIN-PROTEASOME PATHWAY -- PROTEASOME INHIBITORS -- PROTEASOME INHIBITORS IN CANCER -- 25 Poly (ADP-ribose) Polymerase Inhibitors -- INTRODUCTION -- CELLULAR DNA REPAIR PATHWAYS -- THE DEVELOPMENT OF PARP INHIBITORS -- BRCA1 AND BRCA2 MUTATIONS AND DNA REPAIR -- PARP -1 INHIBITION AS A SYNTHETIC LETHAL THERAPEUTIC STRATE GY FOR THE TREAT MENT OF BRCA -DEFICIENT CANCERS -- INITIAL CLINICAL RESULTS TESTING SYNTHETIC LETHALITY OF PARP INHIBITORS AND BRCA MUTATION -- THE USE OF PARP INHIBITORS IN SPORADIC CANCERS -- MECHANISMS OF RESISTANCE TO PARP INHIBITORS -- PROSPECTS -- 26 Miscellaneous Chemotherapeutic Agents -- HOMOHARRINGTONINE AND OMACETAXINE -- L-ASPARAGINASE -- BLEOMYCIN -- PROCARBAZINE. SIROLIMUS AND TEMSIROLIMUS -- VISMODEGIB -- ADO-TRASTUZUMAB EMTANSINE -- SIROLIMUS AND TEMSIROLIMUS -- EVEROLIMUS -- THALIDOMIDE, LENALIDOMIDE, AND POMALIDOMIDE -- 27 Hormonal Agents -- Introduction -- SELECTIVE ESTROGEN RECEPTOR MODULATORS -- AROMATASE INHIBITORS -- GONADOTROPIN-RELEASING HORMONE ANALOGS -- GONADOTROPIN-RELEASING HORMONE ANTAGONISTS -- ANTIANDROGENS -- NOVEL ANTIANDROGENS -- OTHER SEX STEROID THERAPIES -- OTHER HORMONAL THERAPIES -- 28 Antiangiogenesis Agents -- INTRODUCTION -- UNDERSTANDING THE ANGIOGENIC PROCESS -- DRUG DEVELOPMENT OF ANGIOGENESIS INHIBITORS -- CLINICAL UTILITY OF APPROVED ANTIANGIOGENIC AGENTS IN CANCER THERAPY -- COMBINATION THERAPIES -- BIOMARKERS OF ANTIANGIOGENIC THERAPY -- RESISTANCE TO ANTIANGIOGENIC THERAPY -- 29 Monoclonal Antibodies -- INTRODUCTION -- IMMUNOGLOBULIN STRUCTURE -- MODIFIED ANTIBODY-BASED MOLECULES -- FACTORS REGULATING ANTIBODY-BASED TUMOR TARGETING -- UNCONJUGATED ANTIBODIES -- ALTERING SIGNAL TRANSDUCTION -- IMMUNOCONJUGATES -- ANTIBODIES APPROVED FOR USE IN SOLID TUMORS -- ANTIBODIES USED IN HEMATOLOGIC MALIGNANCIES -- CONCLUSION -- 30 Assessment of Clinical Response -- INTRODUCTION -- ASSESSING RESPONSE -- ALTERNATE RESPONSE CRITERIA -- DETERMINING OUTCOME -- PART IV Cancer Prevention and Screening -- 31 Tobacco Use and the Cancer Patient -- Introduction -- NEUROBIOLOGY OF TOBACCO DEPENDENCE -- TOBACCO USE PREVALENCE AND THE EVOLUTION OF TOBACCO PRODUCTS -- TOBACCO USE BY THE CANCER PATIENT -- THE CLINICAL EFFECTS OF SMOKING ON THE CANCER PATIENT -- ADDRESSING TOBACCO USE BY THE CANCER PATIENT -- FUTURE CONSIDERATIONS -- 32 Role of Surgery in Cancer Prevention -- INTRODUCTION -- PATIENTS AT HIGH RISK FOR BREAST CANCER -- HEREDITARY DIFFUSE GASTRIC CANCER -- SURGICAL PROPHYLAXIS OF HEREDITARY OVARIAN AND ENDOMETRIAL CANCER -- HEREDITAR Y ENDOMETRIAL CANCER (LYNCH SYNDRO ME). GYNECOLOGIC CANCER RISK IN VERY RARE HEREDITARY CANCER SYNDRO MES. |
| Altri titoli varianti | Cancer : principles & practice of oncology |
| Record Nr. | UNINA-9910807121703321 |
| Philadelphia, : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Devita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / editors, Vincent T. DeVita, Jr., MD, et al
| Devita, Hellman, and Rosenberg's cancer : principles & practice of oncology / / editors, Vincent T. DeVita, Jr., MD, et al |
| Edizione | [Tenth edition.] |
| Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , 2014 |
| Descrizione fisica | 1 recurso en línea |
| Disciplina | 616.99/4 |
| Soggetto topico | Tumors |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-4698-9455-6
1-4963-2467-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910459782003321 |
| Philadelphia : , : Wolters Kluwer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
DeVita, Hellman, and Rosenberg's cancer [[electronic resource] ] : principles & practice of oncology / / [edited by] Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg
| DeVita, Hellman, and Rosenberg's cancer [[electronic resource] ] : principles & practice of oncology / / [edited by] Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg |
| Edizione | [10th ed.] |
| Pubbl/distr/stampa | Philadelphia, : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2014 |
| Descrizione fisica | 1 recurso en línea |
| Disciplina | 616.99/4 |
| Altri autori (Persone) |
DeVitaVincent T., Jr., <1935->
LawrenceTheodore S RosenbergSteven A |
| Soggetto topico |
Cancer
Oncology Neoplasms |
| ISBN |
1-4698-9455-6
1-4963-2467-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Cancer : principles & practice of oncology |
| Record Nr. | UNINA-9910787258303321 |
| Philadelphia, : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and Management of Pain in Patients with Cancer / / R. Kanner
| Diagnosis and Management of Pain in Patients with Cancer / / R. Kanner |
| Autore | Kanner R |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1988 |
| Descrizione fisica | 1 online resource (VIII + 104 pages) : : 1 figure, 3 tables |
| Disciplina | 616.99/4 |
| Soggetto topico |
Neurology
Oncology Chemotherapy Hospital Care Pharmacology Psychiatry Psychology |
| ISBN | 3-318-04051-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910158698203321 |
|
Kanner R
|
||
| Basel : , : S. Karger, , 1988 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and treatment [[electronic resource]]
| Diagnosis and treatment [[electronic resource]] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2008 |
| Descrizione fisica | 1 online resource (50 p.) |
| Disciplina |
616.99
616.99/4 |
| Collana | Cancer control : knowledge into action : WHO guide for effective programmes |
| Soggetto topico |
Cancer - Diagnosis
Cancer - Treatment Cancer - Patients - Medical care Cancer - Patients - Services for |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-74408-5
9786611744083 92-4-068451-4 92-4-068312-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Diagnosis and Treatment; Series overview; DIAGNOSIS AND TREATMENT: module Contents; Key messages; Key definitions; PRE-PLANNING; PLANNING STEP 1: Where are we now?; PLANNING STEP 2: Where do we want to be?; PLANNING STEP 3: How do we get there?; CONCLUSION; REFERENCES; ACKNOWLEDGEMENTS |
| Record Nr. | UNINA-9910454679603321 |
| Geneva, : World Health Organization, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and treatment [[electronic resource]]
| Diagnosis and treatment [[electronic resource]] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2008 |
| Descrizione fisica | 1 online resource (50 p.) |
| Disciplina |
616.99
616.99/4 |
| Collana | Cancer control : knowledge into action : WHO guide for effective programmes |
| Soggetto topico |
Cancer - Diagnosis
Cancer - Treatment Cancer - Patients - Medical care Cancer - Patients - Services for |
| ISBN |
1-281-74408-5
9786611744083 92-4-068451-4 92-4-068312-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Diagnosis and Treatment; Series overview; DIAGNOSIS AND TREATMENT: module Contents; Key messages; Key definitions; PRE-PLANNING; PLANNING STEP 1: Where are we now?; PLANNING STEP 2: Where do we want to be?; PLANNING STEP 3: How do we get there?; CONCLUSION; REFERENCES; ACKNOWLEDGEMENTS |
| Record Nr. | UNINA-9910782152703321 |
| Geneva, : World Health Organization, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and treatment [[electronic resource]]
| Diagnosis and treatment [[electronic resource]] |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2008 |
| Descrizione fisica | 1 online resource (50 p.) |
| Disciplina |
616.99
616.99/4 |
| Collana | Cancer control : knowledge into action : WHO guide for effective programmes |
| Soggetto topico |
Cancer - Diagnosis
Cancer - Treatment Cancer - Patients - Medical care Cancer - Patients - Services for |
| ISBN |
1-281-74408-5
9786611744083 92-4-068451-4 92-4-068312-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Diagnosis and Treatment; Series overview; DIAGNOSIS AND TREATMENT: module Contents; Key messages; Key definitions; PRE-PLANNING; PLANNING STEP 1: Where are we now?; PLANNING STEP 2: Where do we want to be?; PLANNING STEP 3: How do we get there?; CONCLUSION; REFERENCES; ACKNOWLEDGEMENTS |
| Record Nr. | UNINA-9910806232803321 |
| Geneva, : World Health Organization, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
